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1. Introduction 
Numerous epidemiological studies report consistent associations between exposure to 
urban air pollution and cardio-respiratory morbidity and mortality. One of the important 
discoveries of these epidemiological studies during the last decade was that the increased 
mortality associated with enhanced air pollution exposure was not due only to pulmonary 
diseases, but mainly to cardiovascular diseases. (Zanobetti et al. 2003, Samet et al. 2000, 
Dockery et al. 1993, Jerrett et al. 2005, Pope et al. 2004a, Pope et al. 2002, Simkhovich, 
Kleinman and Kloner 2008, Nawrot, Nemmar and Nemery 2006, Hoek et al. 2002, 
Katsouyanni et al. 2001, Dominici et al. 2003).  
The focus in the initial epidemiological research was directed towards the association 
between both short-term and long-term exposure to air pollution and arterial cardiovascular 
effects, such as myocardial infarction. These landmark studies, in the beginning of the 90's, 
were quickly followed by experimental studies in humans and in rodents, to unravel the 
underlying pathophysiological mechanisms. The number of publications in this field 
increased exponentially, so that by the beginning of 2011, a search through PubMed using 
the MeSH terms 'air pollution' and 'cardiovascular disease' retrieved almost 1300 hits. 
Ambient environmental air pollutants include gaseous (carbon monoxide, nitrogen oxides, 
sulfur dioxide, ozone) and particulate components. The particulate component, particulate 
matter (PM), is subdivided based on size ranges into 'thoracic particles' (PM10, with a mean 
aerodynamic diameter <10 μm), 'coarse particles' (>2.5 μm and <10 μm),  'fine particles' 
(PM2.5, <2.5 μm), and ultra-fine particles (UFP, <0.1 μm). Although exposure to some 
gaseous components has been linked to cardiovascular events, the larger body of evidence 
points towards the deleterious effects of the particulates in air pollution. Therefore, this 
chapter will focus mainly on the cardiovascular morbidity induced by PM exposure. 
Active cigarette smoking has been established as a major independent cause of 
cardiovascular disease (HHS 2004). The inhaled dose of fine particles from ambient air 
pollution, as from secondhand cigarette smoke, is extremely small compared with that from 
active cigarette smoking. Accordingly, the estimated relative risks from active smoking, 
even at relatively light smoking levels, are substantially larger than the risks from ambient 
air pollution or secondhand smoke. However, the risks induced by these latter 2 types of 
exposure are higher than would be expected from a simple linear extrapolation based on the 
amount of inhaled PM from active smoking (Pope et al. 2009), and have important public 
health implications (Nawrot et al. 2011). 
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Arterial and venous thrombosis share common risk factors (Lowe 2008). The role of air 
pollution exposure as a risk factor for arterial events now being beyond discussion, a few 
years ago, epidemiologists started investigating a possible association with venous 
thrombotic events. Thus, in 2008, Baccarelli et al. demonstrated a link between chronic 
exposure to elevated levels of air pollution and deep vein thrombosis (DVT) for the first 
time. To understand the pathophysiological mechanisms underlying the observed link 
between air pollution and cardiovascular morbidity, one should take into account the 
complex interplay of prohemostatic and antihemostatic mechanisms, with different 
protagonists for the arterial and the venous vasculature. The human cardiovascular system 
consists of a functional vascular network for blood distribution, subdivided in a systemic 
and pulmonary circulatory system. The systemic circulation transports oxygenated blood 
through the arteries from the left heart to the organs and returns oxygen-depleted blood 
through the veins to the lungs. The pulmonary circulation subsequently transports the 
oxygen-depleted blood from the heart to the lungs, where it is oxygenated and returned to 
the heart. 
Vascular integrity throughout the vascular tree is maintained by the vessel wall itself, as 
well as by a complex hemostatic mechanism involving blood platelets and coagulation 
factors.  
The critical need to rapidly form a stable, localized clot in response to vascular injury 
(='hemostasis') must be balanced with the need to maintain blood flow within the vessels. 
Different antihemostatic mechanisms prevent clot formation under resting physiological 
conditions, and limit clot growth to the site of vascular injury. When prohemostatic 
tendencies proceed beyond the physiological need to maintain vascular integrity, a 
pathological thrombus may form, obstructing the normal blood flow (='thrombosis'). In the 
arterial system, thrombus formation induces oxygen-deprivation (ischemia) of the 
downstream tissues, such as myocardial infarction and cerebral ischemia.  The formation of 
an arterial thrombus largely depends on the activation of blood platelets, and is most often 
triggered by the rupture of an atherosclerotic plaque. Indeed, the chronic localized 
deposition of lipids into the arterial vessel wall (atherosclerosis) leads to the formation of 
plaques that can rupture when unstable, hereby exposing their procoagulant contents to the 
circulation (Ross 1999). Hence, while often being asymptomatic in itself over many years, 
atherosclerosis formation may cumulate into an acute burst of symptomatic arterial 
thrombus formation.  
In the venous system, thrombus formation results from a decrease in blood flow, in 
conjunction with a hypercoagulable state and endothelial dysfunction (Virchow's triad), and 
most often affects the deep veins of the legs (deep vein thrombosis, DVT). The most serious 
complication of DVT is the embolisation of clot dislodgements to the lungs (pulmonary 
embolism, PE). 
The following paragraphs will describe how air pollutants affect arterial and venous 
functionality and lead to pathophysiological manifestations. 
2. Particle triggered pathophysiological mechanisms 
Inhaled particles deposit in various segments of the human respiratory tract. While the 
larger PM10 particles impact to a large extent in the nasopharyngeal and tracheal region, the 
smaller PM2.5 particles penetrate deeper into the bronchi and bronchioli, whereas the UFP 
reach the alveolar regions. Inhaled particles are believed to affect the cardiovascular system 
www.intechopen.com
 
Air Pollution and Cardiovascular Disease 
 
71 
through 3 different pathways: interference with the autonomic nervous system, direct 
translocation of UFP into the systemic circulation and pulmonary inflammation. 
PM inhalation deranges the autonomic nervous control of the heart (Brook et al. 2004). 
Numerous studies (e.g. (Park et al. 2010, Pope et al. 1999)) have shown that, by reducing the 
heart rate variability, PM may increase the risk for cardiac arrhytmias and sudden death . In 
addition, elevations in air pollution have been associated with ST-segment depression 
(Pekkanen et al. 2002, Mills et al. 2007), an impaired cardiac deceleration capacity (Schneider 
et al. 2010), hypertension (Ibald-Mulli et al. 2001) and increased diastolic blood pressure 
(Urch et al. 2005). The exact underlying mechanisms remain to be elucidated, but 
stimulation of irritant receptors in the airways and subsequent reflex activation of the 
nervous system as well as direct effects of pollutants on cardiac ion channels have been 
suggested (Brook et al. 2004, Pope et al. 2004b). 
A second mechanism of action comprises the translocation of inhaled particles into the 
systemic circulation. Direct effects may occur via UFP that readily cross the pulmonary 
epithelial barrier, along with soluble constituents released from the larger particles (e.g. 
transition metals). Systemic translocation of particles was demonstrated in experimental 
animal models (Nemmar et al. 2001) (Oberdorster et al. 2002). Although evidence of 
systemic translocation from human studies is less clear, with both positive (Nemmar et al. 
2002, Pery et al. 2009) and negative (Mills et al. 2006) findings, it is likely that this pathway 
also exists in humans, given the deep penetration of UFP into the alveoli and the close 
apposition of the alveolar wall and the capillary network. Radioactivity in the systemic 
circulation was already detected 1 minute after the inhalation of radioactively labelled 
carbon particles in humans, with peak radioactivity levels between 10 and 20 minutes 
(Nemmar et al. 2002). When measured in rats under resting conditions, only a small fraction 
(1.6-2.5%) of intratracheally instilled UFP translocated into the circulation. However, this 
fraction increased to 4.7% following pretreatment of the lungs with lipopolysaccharides, 
suggesting a role for pulmonary inflammation in enhancing the extrapulmonary 
translocation of particles (Chen et al. 2006). Different translocation mechanisms, ranging 
from endocytosis by alveolar type I and endothelial cells, over phagocytosis by 
macrophages to passage through widened tight junctions are recognized and depend on the 
particle surface chemistry (Oberdorster, Oberdorster and Oberdorster 2005). However, a 
detailed description of the different pathways is beyond the scope of this article. Once UFP 
have translocated to the blood circulation, they can be distributed throughout the body, and 
interact with the vascular endothelium or circulating cells, such as blood platelets and 
leukocytes. 
Inhaled PM executes its deleterious effects also via a third, more chronic mechanism, 
namely pulmonary inflammation and oxidative stress. Exposure to PM induces a 
proinflammatory response in human lungs (Ghio, Kim and Devlin 2000), consistent with 
observations in in vivo animal models (Nemmar et al. 2003c, Emmerechts et al. 2010) and in 
vitro cellular models (Mitschik et al. 2008, Alfaro-Moreno et al. 2008). The presence of 
soluble transition metals in PM enhances the inflammatory responses via increased 
oxidative stress (Jiang et al. 2000). The PM-induced pulmonary inflammation is followed by 
the release of inflammatory cytokines, such as interleukin (IL)-1β, IL-6 and granulocyte 
macrophage colony-stimulating factor (van Eeden et al. 2001) in the circulation, resulting in 
the release of bone-marrow derived neutrophils and monocytes (Tan et al. 2000).  
The generation of a systemic inflammatory response, mostly demonstrated by increases in 
C-reactive protein (CRP) (Peters et al. 2001b, Hertel et al. 2010), is of major importance in the 
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pathogenesis of cardiovascular events. Upon PM exposure, IL-6 translocates from the lung 
into the systemic circulation (Kido et al. 2011) and is directly involved in the regulation of 
the synthesis of CRP in the liver. Elevated concentrations of IL-6 are associated with an 
increased risk of cardiovascular events (Ridker et al. 2000, Lindmark et al. 2001) and 
mortality (Volpato et al. 2001). Knock-out mice that lacked IL-6 were protected against the 
prothrombotic effects of PM exposure (Mutlu et al. 2007). Increasing evidence points to an 
extensive cross-talk between inflammation and hemostasis, whereby inflammation leads to 
activation of blood platelets and of coagulation, and activated blood platelets and 
coagulation factors also considerably contribute to the inflammatory action (Levi and van 
der Poll 2010). 
In the following paragraphs, the deleterious effects of PM exposure on arterial and venous 
parameters will be discussed. By virtue of their respective protagonist roles, blood platelet 
activation will mainly be discussed in the paragraph on arterial events, while coagulation 
activation will mainly be discussed in the paragraph on venous events. Formally, arterial 
thrombosis, the basis for myocardial infarction, is the result of vessel wall injury and 
formation of a platelet-rich thrombus. Venous thrombosis, the basis for VTE (venous 
thromboembolism) results from coagulation activation and formation of a fibrin-rich 
thrombus. It should be noted, however, that both blood platelet and coagulation activation 
intervene in arterial and venous thrombosis, and that both systems highly interact with each 
other (Prandoni 2009).  
3. Air pollution and arterial events 
Over the last 2 decades, a vast number of epidemiological studies (reviewed in (Maitre et al. 
2006)) have provided convincing evidence to conclude that chronic exposure to PM 
enhances atherosclerosis and that acute exposure increases the risk of atherosclerotic plaque 
rupture, triggering arterial thrombosis, myocardial infarction and cardiovascular mortality. 
Relative risk levels for cardiovascular disease may differ between different studies, due to 
differences in study design. Short-term effects have been most often studied in time-series 
and case-crossover studies, while long-term effects have been studied in case-control and 
cohort studies. Relative risk levels are generally lower in time series studies than in other 
epidemiological designs. Nevertheless, the associations between cardiovascular disease and 
PM exposure are consistent, whatever the type of method used (Maitre et al. 2006). 
An initial landmark report was that of the Harvard Six Cities study (Dockery et al. 1993), in 
which a cohort of 8111 adults were followed up for 14 to 16 years. The adjusted overall 
mortality rate for the most polluted city vs. the least polluted was 1.26 (95%CI 1.08-1.47). 
Cardiovascular deaths accounted for the largest single category of increased mortality. Each 
10 μg/m3 increase in long-term levels of PM2.5 has been associated with a 8 to 18% increase 
in cardiovascular mortality (Pope et al. 2004a). An association with mortality was also found 
for traffic-related air pollution and several traffic exposure variables, although relative risks 
were small (Beelen et al. 2008). The effects of long-term PM exposure on cardiovascular 
mortality have been shown elegantly by the demonstration of a parallelism between air 
quality improvement and reduction in cardiovascular events on a population-based level 
(Laden et al. 2006, Boldo et al. 2011). A potential benefit in general mortality can be expected 
within 2 years after the reduction of PM exposure (Schwartz et al. 2008). 
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The magnitude of these associations appeared to be more pronounced for the smaller PM2.5 
fraction than for the larger PM10 fraction (Puett et al. 2009). Considering a large body of 
evidence, a recent updated version of the American Heart Association scientific statement 
on 'Air Pollution and Cardiovascular Disease' (Brook et al. 2010) concluded that per 10 
μg/m3 increase in long-term levels of PM2.5, all-cause mortality increased by an approximate 
10%. The mortality risk specifically related to cardiovascular disease appears to be elevated 
to a similar, or perhaps even greater extent, ranging from 3 to 76% over different studies. 
3.1 Chronic PM exposure and atherosclerosis 
What etiological agent can explain the link between chronic air pollution exposure and 
cardiovascular mortality? Künzli et al. provided the first epidemiological evidence for an 
association with atherosclerosis: living in the areas of Los Angeles with highest annual mean 
concentrations of ambient PM2.5 was associated with an increased intima-media thickness of 
the carotid artery (Kunzli et al. 2005).  
Distance from the residence to a major road correlated with the degree of coronary artery 
calcification, a measure for atherosclerosis (Hoffmann et al. 2007).  
Another study in 5172 adults investigated 20-year PM exposure and found an association, 
although weaker than in the previous studies, with carotid intima media thickness, but not 
with other measures of atherosclerosis i.e. coronary calcium and ankle brachial index (Diez 
Roux et al. 2008).  
A recent study demonstrates that long-term PM exposure is not only related to the degree, 
but also to a faster progression rate of atherosclerosis (Kunzli et al. 2010). 
Along with this epidemiological evidence, experimental research also established a link 
between exposure to PM and the development of atherosclerosis. Repeated exposure to 
PM10 in rabbits was associated with both systemic inflammation and the progression of the 
atherosclerotic process, the extent of which correlated with the extent of PM10 phagocytosed 
by alveolar macrophages (Suwa et al. 2002).  
Exposing genetically susceptible apolipoprotein E-null mice for 6 months to an equivalent 
concentration of 15.2 µg/m3 PM2.5 over a lifetime, enhanced abdominal aortic plaque 
formation as compared to mice exposed to filtered air (Sun et al. 2005). Interestingly, 
ultrafine (<0.18 μm) particle-exposed mice exhibited significantly larger atheroslerotic 
lesions than mice exposed to fine (<2.5 μm) particles or filtered air (Araujo et al. 2008). 
Atherosclerosis is now considered an inflammatory disease with low density lipoprotein 
(LDL) cholesterol accumulation in the arteries as the primary risk factor (Ross 1999). 
However, up to 50% of the patients who develop atherosclerosis do not have high 
cholesterol (Braunwald 1997). Therefore, it is the relationship between the accumulated 
lipids and other harmful components of inflammation in the arterial vessel wall that is of 
concern. LDL infiltration of the arterial vessel wall is followed by oxidative modification to 
oxidized LDL (ox-LDL) in the subendothelial space and chemotaxis of monocytes. These 
monocytes differentiate into macrophages and the subsequent phagocytosis of ox-LDL leads 
to the formation of foam cells and the release of inflammatory mediators, inducing a vicious 
cycle of inflammation. Further stages include smooth muscle cell proliferation, formation of 
a fibrous cap with necrotic core and calcification (Ross 1999). Thickening of the vessel wall 
and obliteration of the vascular lumen induces downstream ischemia of the tissues.  
PM exposure can induce atherosclerosis via different pathways:  systemically translocated 
UFP or their chemical constituents induce activation of proatherogenic molecular 
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pathways in endothelial cells, by oxidative stress. Inflammatory mediators released from 
the lungs may promote chemotaxis of monocytes into the vessel wall. PM induces high-
density lipoprotein (HDL) dysfunction with loss of its anti-inflammatory properties 
(Araujo and Nel 2009). 
Oxidative transformation of LDL into ox-LDL is a key step in the initiation and progression 
of atherosclerosis (Stocker and Keaney 2004), and circulating levels of ox-LDL are therefore 
an early marker, and a risk factor for the disease (Wallenfeldt et al. 2004). The correlation 
between PM exposure and circulating levels of ox-LDL on an individual level was shown by 
Jacobs et al., demonstrating a dose-dependent  association between this parameter and the 
carbon load of airway macrophages, a personal marker for chronic exposure to fossil fuel 
derived ultrafine particles (Jacobs et al. 2011). 
It has been previously shown that particles can induce oxidative stress both in vitro 
(Jimenez et al. 2000, Carter et al. 1997) and in exposed animals (Costa and Dreher 1997, 
Kadiiska et al. 1997, Tao, Gonzalez-Flecha and Kobzik 2003, Araujo et al. 2008).  
In agreement with epidemiological findings (Puett et al. 2009), experimental studies suggest 
that the smaller particles are more pathogenic, as a result of their greater propensity to 
induce systemic prooxidant and proinflammatory effects (Araujo et al. 2008). Indeed, 
ambient UFP trigger the induction of the antioxidant gene heme oxygenase 1 (HO-1) to a 
higher degree than ambient PM2.5 or coarse particles, both in vitro (Li et al. 2004) and in vivo 
(Araujo et al. 2008, Araujo and Nel 2009). Several mechanisms contribute to the greater 
proatherogenic potential of UFP: because of their small size, particles < 0.1-0.2 μm contribute 
very little to overall PM2.5 mass. However, they represent >85-90% of the total PM2.5 particle 
number (Sioutas, Delfino and Singh 2005). The high number of UFP, in conjunction with a 
large surface-to-mass ratio increases the bioavailability of the pro-oxidant chemicals 
(polycyclic aromatic hydrocarbons, transition metals etc.) present on the UFP's surface. The 
number of chemicals that are displayed on the surface of particles increases exponentially as 
the size shrinks below 100 nm (Oberdorster et al. 2005). Deep penetration in the lung and 
subsequent translocation of UFP into the circulation make these pro-oxidant chemicals more 
bioavailable at the contact sites of the particles with cells and tissues. 
3.2 Acute PM exposure and arterial thrombosis 
Not only chronic, but also short-term PM exposure has been linked to cardiovascular 
mortality: Both the American NMMAPS (National Morbidity, Mortality, and Air Pollution 
Study (Dominici et al. 2003)) and the European APHEA2 (Air Pollution and Health: A 
European Approach (Katsouyanni et al. 2001, Zanobetti et al. 2003)) studies (approximately 
50 million and 43 million persons included respectively) demonstrated small increases in 
cardiovascular mortality with increasing PM exposure. In an attempt to evaluate the 
coherence of studies across continents, the APHENA (A Combined European and North 
American Approach) analyzed data of these 2 aforementioned studies and Canadian studies 
(Samoli et al. 2008). The combined effect on all-cause mortality ranged from 0.2% to 0.6% for 
a 10 μg/m3 increase in daily levels of ambient PM10, with greater effects for the elderly (>75 
years) and the unemployed. An extensive review of studies investigating a link between 
short-term PM exposure and cardiovascular mortality is provided in (Brook et al. 2010). 
Peters et al. (Peters et al. 2001a) demonstrated an increased risk of myocardial infarction in 
association with elevated concentrations of fine PM2.5, both in the previous 2-hours period 
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and the day before the onset. Likewise, the onset of myocardial infarction was linked to 
participation in traffic, as soon as 1 h afterward (odds ratio 2.92, 95%CI 2.22-3.83) (Peters et 
al. 2004). 
Exposure to ambient PM2.5 is associated with short-term increases in hospital admission 
rates for cerebrovascular, peripheral and cardiac ischemic disease, heart rhythm and heart 
failure, with the strongest association for heart failure (1.28 % 95%CI 0.78-1.78% increase in 
risk per 10 μg/m3 increase in same-day PM2.5) (Dominici et al. 2006). 
The risk of mortality from coronary heart disease related to PM exposure appears to be 
higher in women (RR  1.42, 95%CI 1.06-1.90) than in men (RR 0.90, 95%CI 0.76-1.05 per 10 
μg/m3 increase in PM2.5)(Chen et al. 2005). In a study of 65893 postmenopausal women with 
a median follow-up of 6 years, each increase in long-term levels of PM2.5 of 10 μg/m3, 
measured at the women's residence, was associated with a 24% (95%CI 09-41%) increase in 
the risk of a cardiovascular event, and a 76% (95%CI 25-147%) increase in the risk of death of 
cardiovascular disease (Miller et al. 2007). 
Although the magnitude of the risk on myocardial infarction induced by short-term PM 
exposure is rather small on a personal level, it is of major importance on a population level, 
by virtue of the large number of people exposed. Taking into account both risk magnitude 
and risk prevalence by measurement of the population attributable fraction (PAF), Nawrot 
et al. showed that a short-term increase in air pollution exposure is an important trigger for 
myocardial infarction, of similar magnitude (PAF 5-7%) as other well accepted triggers such 
as physical exertion, alcohol and coffee (Nawrot et al. 2011). 
Epidemiological studies suggest an association between short-term increases in PM 
exposure and atherosclerotic plaque rupture, causing arterial thrombosis and myocardial 
infarction. In contrast to the growing number of mechanistic studies investigating the role of 
chronic PM exposure on atherogenesis, the precise mechanisms explaining the role of short-
term PM exposure in acute plaque rupture largely remain to be elucidated. However, 
several epidemiological and mechanistic studies demonstrated that, in parallel to 
atherosclerotic plaque rupture, direct or indirect activation of circulating blood platelets by 
PM contributes to the arterial thrombosis risk. Indeed, the extent to which a growing 
thrombus occludes the vascular lumen may in part depend on platelet hyperactivity. 
Under physiological circumstances, the high blood pressure generated on the arterial side of 
the circulation requires a powerful, almost instantaneous prohemostatic response in order to 
minimize blood loss from sites of vascular injury. Blood platelets play a critical role in this 
response. Upon damage of the endothelial cell layer covering the luminal side of blood 
vessels, circulating blood platelets adhere to the exposed subendothelial matrix through the 
binding of the glycoprotein (GP) Ib-IX-V receptor to exposed von Willebrand factor (vWF). 
Blood platelet adhesion is further enhanced by the binding of different GP receptors to other 
subendothelial matrix proteins, such as collagen and fibrin(ogen). Upon adhesion and 
activation of the blood platelets by various agonists, vWF and fibrinogen molecules cross-
link different platelets, resulting in blood platelet aggregation and the formation of an initial 
platelet plug which covers the site of endothelial lesion. The simultaneous activation of the 
coagulation cascade leads to the formation of a network of insoluble fibrin strands that 
further stabilize the initial platelet plug.  
Air pollution exposure can induce an inappropriate activation of blood platelets beyond the 
physiological need to restore vessel damage, resulting in arterial thrombosis (Fig. 1).  
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BP: blood platelet, PM: particulate matter, TF: tissue factor, UFP: ultra-fine particles 
Fig. 1. Biological pathways linking PM exposure and arterial thrombosis 
By exposing healthy volunteers to diluted diesel exhaust, Lucking et al. showed an associa-
tion with enhanced platelet activity and thrombus formation in an ex vivo perfusion 
chamber, 2 hours and 6 hours after exposure, in conjunction with increased numbers of 
platelet-neutrophil (+52%) and platelet-monocyte (+30%) conjugates (Lucking et al. 2008). 
Short-term, but not long-term PM exposure was found to enhance platelet function, as 
measured ex vivo by a shortening of the closure time of the Platelet Function Analyzer (PFA-
100, Siemens Healthcare Diagnostics), in patients with diabetes (Jacobs et al. 2009). In this 
study, an interquartile range (39.2 μg/m3) increase in the PM10 concentration, measured 2 
hours before the clinical investigation at the entrance of the hospital, was associated with a 
decrease of 21.1 sec (95%CI -35.3 to -6.8) in the PFA-100 closure time. Platelet function was 
not correlated with leukocyte counts, suggesting that short-term PM exposure may have 
effects on platelet function independently of systemic inflammation, as was also shown in 
experimental animal models (Nemmar et al. 2003c).  
Ambient PM10 levels have also been associated with augmented platelet aggregation 24 to 96 
hours after exposure in healthy adults, in the absence of increased CRP or fibrinogen (Rudez 
et al. 2009). In patients with coronary heart disease, mean concentrations over 24 hours of 
ambient UFP, but not PM2.5 or PM10 were positively associated with the levels of soluble 
CD40 ligand, a marker for platelet activation. No assocations were found with longer time 
frames, up to 5 days (Ruckerl et al. 2007b). 
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In experimental conditions using DEP, Nemmar et al. demonstrated a prothrombotic 
tendency and activation of circulating blood platelets (confirmed by PFA-100), as well as 
lung inflammation, which persisted up to 24 hr after intratracheal instillation of DEP in 
hamsters (Nemmar et al. 2003a, Nemmar et al. 2003c).  
However, different pathophysiological mechanisms seem to be responsible for the observed 
prothrombotic risk at different time points. Pretreatment of hamsters with a histamine H1-
receptor antagonist, an anti-inflammatory drug, abolished pulmonary inflammation at all 
time points and reduced DEP-induced thrombosis at 6 and 24 hours post-instillation, 
indicating a crucial role for inflammation in thrombogenicity at these time points. Likewise, 
the administration of other anti-inflammatory drugs, such as dexamethasone and selective 
inhibitors of basophils, macrophages and neutrophils, also significantly reduced the PM-
induced prothrombogenicity at 24 hours (Nemmar et al. 2004, Nemmar et al. 2005). 
In contrast, pretreatment with the histamine H1-receptor antagonist did not reduce 
thrombosis as soon as 1 hour after DEP exposure (Nemmar et al. 2003c). Therefore, the early 
prothrombotic tendency appears not to result from pulmonary inflammation, but possibly 
from direct effects of systemically translocated particles on the blood platelets and/or the 
(pulmonary) vessel wall (Nemmar et al. 2003c). The direct activating effect of PM on blood 
platelets was shown by the addition of as little as 0.5 μg/mL DEPs to untreated hamster 
blood, significantly shortenening the PAF-100 closure time (Nemmar et al. 2003a), as well as 
by a dose-dependent (0.1-1 μg/mL) effect of PM on in vitro platelet aggregation in rat blood 
(Nemmar et al. 2010), although similar experiments in human blood were negative (Rudez 
et al. 2009).  
In agreement with these results, 1 hour after intratracheal instillation, well-defined 
positively charged ultrafine (60 nm) polystyrene particles significantly enhanced platelet-
rich thrombus formation, while 400 nm particles, incapable of systemic translocation, did 
not affect thrombus formation, despite similar increases in neutrophils, lactate 
dehydrogenase and histamine levels in the bronchoalveolar lavage fluid (Nemmar et al. 
2003b).  
Pulmonary instillation of carbon nanotubes elevated platelet-leukocyte conjugates at 6 hours 
and increased the peripheral thrombotic potential at 24 hours after exposure. Inhibition of P-
selectin abrogated these responses (Nemmar et al. 2007). P-selectin is found in storage 
Weibel-Palade bodies of endothelial cells and in α-granules of platelets, from where it can be 
expressed on the outer membrane upon activation. Surface expression of P-selectin initiates 
capture and rolling of circulating leukocytes over stimulated endothelium (Theilmeier et al. 
2002) and the formation of platelet-leukocyte conjugates (Yokoyama et al. 2005). Increased 
levels of platelet-leukocyte conjugates have been demonstrated in Indian women who used 
biomass as cooking fuel, producing higher levels of PM, as compared to women cooking 
with a cleaner fuel (liquefied petroleum gas) (Ray et al. 2006). In a panel study of 60 elderly 
subjects with coronary artery disease, Delfino et al. demonstrated associations between 
soluble P-selectin levels and the mean 1 to 5-day concentrations of ambient finer particles 
(PM0.25 and PM2.5), but not the bigger PM10 (Delfino et al. 2009). Taken together, these studies 
suggest that the release of pulmonary cell-derived mediators (eg. histamine) and the 
expression of endothelial and platelet surface proteins (eg. P-selectin) after several hours, 
along with the more rapid activation of circulating platelets by direct contact with UFP may 
mediate peripheral prothrombotic effects. 
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4. Air pollution and venous thromboembolism 
4.1 Epidemiology 
In addition to the well-recognized PM-related adverse effects on the arterial vascular 
system, recent epidemiological evidence also suggests an association between exposure to 
PM and venous thromboembolism (VTE). Baccarelli et al. reported a 70% increase in the risk 
of deep vein thrombosis (DVT) for each 10 μg/m3 increase of the annual mean level of PM10 
in the areas of residence of the study subjects (OR 1.70, 95%CI 1.30-2.23) (Baccarelli et al. 
2008). The observed exposure-response relationship was approximately linear over the 
observed PM10 range, so that PM10 at the higher concentrations within the international 
limits can still increase the risk of DVT, as compared to the lowest concentration measured. 
These authors found, in the same study subjects, that living near major traffic roads was also 
associated with an increased risk of DVT, even after controlling for the community-level PM 
pollution (Baccarelli et al. 2009). Very recently, exposure to PM has also been associated with 
hospital admission for VTE in Chile. Both for DVT and for PE, pooled estimates of relative 
risk of hospitalization were 1.05 (95%CI 1.03-1.06) for a 20.02 μg/m3 increase in PM2.5 (Dales, 
Cakmak and Vidal 2010). 
However, these initial epidemiological reports on the association between air pollution 
exposure and venous thrombosis were followed by a number of prospective cohort studies 
that failed to demonstrate an association: 26,450 post-menopausal women, enrolled in the 
Women's Health Initiative (WHI) Hormone Therapy trials, were randomized to treatment 
with either hormone therapy or placebo. Regardless of the treatment category, no evidence 
was found of an association between short- or long-term (up to 1 year) PM exposure and 
VTE (Shih et al. 2010). Of note, the aforementioned study of Baccarelli et al. also observed 
lower PM-induced VTE risk among women compared to men (Baccarelli et al. 2008). A 
prospective study in 13,134 middle-aged persons, including men and women, also provided 
evidence against an association between VTE and long-term air pollution exposure, as 
assessed by residential distance to a major road (Kan et al. 2011).  
Hence, in contrast to the well-accepted and documented deleterious effects of air pollution 
exposure on arterial events, data are scarce and the link with venous thrombosis is less 
straightforward, prompting further epidemiological investigation. 
4.2 Pathophysiology 
At lower rates of shear found in the venous circulation, the contribution of blood platelets to 
clot formation is of lesser importance than in the arterial circulation, leaving a protagonist 
role for the coagulation cascade in venous hemostasis. Activation of the coagulation cascade 
is initiated by activation of coagulation factor VII (FVII) by binding to tissue factor (TF), 
expressed on subendothelial cells such as fibroblasts and vascular smooth muscle cells. The 
complex of TF and activated FVII (FVIIa) initiates a cascade of subsequent coagulation factor 
activations, resulting in the generation of thrombin. Thrombin (FII) is a key enzyme, 
converting fibrinogen monomers to fibrin polymers that clot into a fibrin plug, and 
amplifying the coagulation cascade through activation of FV, FVIII and FXI. 
The mechanisms underlying the observed increase in venous thrombosis in association with 
exposure to air pollution remain largely unknown, and published results with regard to 
markers of secondary hemostasis activation are conflicting. Although some epidemiological 
and controlled exposure studies demonstrated an association between PM exposure and 
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shortening of the prothrombin time (PT) or increased levels of fibrinogen and vWF, others 
failed to demonstrate positive associations with these or other markers of coagulation, in 
humans (Table 1). In fact, disappointingly few studies reported on PM-induced coagulatory 
changes that could form the basis for the observed link between air pollution and DVT. 
How can this conundrum of PM-induced DVT in the absence of a procoagulant phenotype 
be explained? 
One explanation for the lack of positive associations between PM exposure and 
measurement of parameters of coagulation might be found in the short observation time 
frame that was used in most studies. While short-term PM exposure enhances blood platelet 
activation, a more chronically sustained exposure appears to be necessary to induce 
significant changes in the coagulatory cascade.  
This hypothesis is corroborated by epidemiological findings in which the risk for DVT was 
only associated with the mean PM concentration over a one year period, and not with any 
shorter time-point (Baccarelli et al. 2008). This was confirmed by animal studies in which 
short- term exposure of healthy mice to intratracheally instilled DEP or UPM enhanced 
arterial, but not venous thrombosis (Emmerechts et al. 2010). In this study, even very high 
doses of PM (up to 200 μg/mouse), given as a single dose, induced only mild increases in 
the levels of FVII, FVIII and fibrinogen. Likewise, exposure of rats to concentrated PM from 
New York City air did not alter levels of fibrinogen, FVII or thrombin-antithrombin 
complexes (TAT) (Nadziejko et al. 2002). 
Significant increases in the level of fibrinogen, or decreases in the levels of the anticoagulant 
proteins activated protein C or tissue factor pathway inhibitor (TFPI) upon short-term PM 
exposure have been observed in rodents, but at doses of 100 μg or higher per mouse (Cozzi 
et al. 2007, Inoue et al. 2006). One study stands out among other studies on procoagulant 
changes and PM exposure: Mutlu et al. observed a pronounced prothrombotic phenotype in 
mice upon a single intratracheal instillation of as few as 10 μg of PM10, characterized by 
shortenings in bleeding time, PT and aPTT, and relatively high increases in the levels of 
circulating blood platelets, FVII, FVIII, FX and fibrinogen (Mutlu et al. 2007). The reason for 
the discrepancy between this and other studies being unclear, this study is of value since it 
demonstrated the absence of a PM-induced prothrombotic phenotype in interleukin-6 (IL-6) 
knock-out mice, recognizing a major role of inflammatory factors in the induction of 
procoagulant changes following PM exposure. 
Indeed, although some studies suggest a short-term effect of directly translocated UFP 
through the activation of the coagulation cascade via contact activation, as demonstrated in 
vitro (Kilinc et al. 2010), evidence seems to favor a more prominent role for inflammatory 
changes related to chronic PM exposure. In this context, it is of interest that the only 
coagulation factor for which the associations with air pollution were consistent over 
different studies in humans is fibrinogen (Table 1), an acute phase protein that is 
upregulated during inflammatory processes. 
However, although considered to be a (minor) risk factor, elevated levels of fibrinogen seem 
unlikely to be solely responsible for the PM-induced increased risk of DVT. 
Through the expression of procoagulant proteins and lipids on their surface, microvesicles 
(also called microparticles, a term we prefer to avoid in the context of pollution by particles) 
could offer an alternative explanation. Microvesicles are circulating vesicles released from 
stimulated or apoptotic cells in the vasculature, or during thrombogenesis in the bone 
marrow, with a mean diameter smaller than 1 μm. Through their surface expression of 
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reference subjects exposure coagulatory changes 
author + 
year 
n type 
mean age 
(SD or 
range) 
gender 
(% male)
controlled 
exposure 
type of air 
pollution 
exposure 
time 
significant 
changes 
no 
significant 
changes 
(Seaton et 
al. 1999) 
112 NA 70 (7) ? no 
ambient 
PM10 
3 days FVII (-), fbg (-)  
(Ghio et al. 
2000) 
38 
healthy 
subjects 
26 ( 0.7) 95 yes 
concentrated 
PM2.5 
2h fbg  
(Pekkanen 
et al. 2000) 
7205 
healthy 
subjects 
NA 69 no 
ambient 
PM10 
1-3 days fbg  
(Ghio et al. 
2003) 
20 
healthy 
subjects
25 (0.8) 70 yes 
concentrated 
PM2.5
2h fbg 
D-dim, PC, 
vWF 
(Riediker 
et al. 2004) 
9 
healthy 
subjects
27 (23-30) 100 no 
in-vehicle 
PM2.5
9h vWF  
(Beckett et 
al. 2005) 
12 
healthy 
subjects
35 (23-52) 50 yes 
zinc oxide 
particles
2h  
fbg, FVII, 
vWF 
(Blomberg 
et al. 2005) 
15 
COPD 
patients
66 (56-72) NA yes 
diesel 
exhaust
1h  
fbg, D-dim, 
vWF 
(Barregard 
et al. 2006) 
13 
healthy 
subjects
34 (20-56) 46 yes wood smoke 4h FVIII 
fbg, FVII, D-
dim, vWF 
(Ruckerl et 
al. 2006) 
57 
CHD 
patients 
66 ( 6) 100 no 
ambient 
PM2.5 and 
PM10
1-5 days FVII (-), vWF fbg, D-dim 
(Baccarelli 
et al. 2007) 
1218 
healthy 
subjects
44 (11-84) 40 no 
ambient 
PM10
t0 - 30days PT 
aPTT, fbg, 
AT, PC, PS 
(Carlsten 
et al. 2007) 
13 
healthy 
subjects
25 (20-42) 85 yes 
diesel 
exhaust
2h  D-dim, vWF 
(Chuang et 
al. 2007) 
76 
healthy 
students
21 (18-25) 65 no 
ambient 
PM2.5 and 
PM10
1-3 days fbg  
(Ruckerl et 
al. 2007a) 
1003 
MI 
survivors
65 (45-78) 69 no 
ambient 
PM2.5 and 
PM10
1-4 days fbg  
(Scharrer 
et al. 2007) 
20 
healthy 
subjects
29 ( 8) 60 yes 
welding 
fume
1h  
FVIII, vWF, 
AT 
(Brauner et 
al. 2008) 
41 
healthy 
subjects
67 (60-75) 51 yes 
indoor PM2.5
and PM10
2 days  
fbg, 
FII+VII+X 
(Lucking 
et al. 2008) 
20 
healthy 
subjects 
26 (21-44) NA yes 
diesel 
exhaust 
1-2h  PT, aPTT 
(Rudez et 
al. 2009) 
40 
healthy 
subjects
41 (15) 35 no 
ambient 
PM10
6h-4days  fbg,TG 
(Samet et 
al. 2009) 
19 
healthy 
subjects 
18-35 53 yes 
concentrated 
ambient 
UFP
2h D-dim 
fbg, FIX, 
FXII, vWF 
(Bonzini et 
al. 2010) 
37 
steel plant 
workers
42 (7) 100 no 
occupational 
PM10
1-3 days PT,TG aPTT, D-dim 
(Stewart et 
al. 2010) 
19 
T2DM 
patients
48 (9) 47 yes carbon UFP 2h  
FVII, FIX, D-
dim, TF 
(Thompson 
et al. 2010) 
45 
healthy 
subjects
27 (19-48) 49 no 
ambient 
PM2.5
t0 - 7 days  fbg 
(Jacobs et 
al. 2011) 
70 
DM 
patients 
57 (14) 53 no 
carbon load 
in alveolar 
Mφ
NA  vWF 
COPD: chronic obstructive pulmonary disease, MI: myocardial infarction, CHD: coronary heart disease, 
DM: diabetes mellitus, T2DM: type 2 diabetes mellitus, PM: particulate matter, UFP: ultra-fine particles, 
Mφ: macrophages, PT: prothrombin time, aPTT: activated partial prothrombin time, AT: antithrombin, 
PC: protein C, PS: protein S, F: factor, fbg: fibrinogen, D-dim: D-dimers, vWF: von Willebrand factor, 
TG: thrombin 
Table 1. Associations between PM exposure and coagulatory changes according to different 
studies. 
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negatively charged phospholipids and of tissue factor (TF), they create a procoagulant 
surface on which coagulation factors can bind and be activated (Morel et al. 2006). Indeed, 
the initial concept that TF presence is limited to a hemostatic envelope surrounding blood 
vessels has been challenged by the identification of 'blood borne' TF, either on circulating 
white blood cells or microvesicles, as a soluble protein, or possibly on stimulated endothelial 
cells (Pawlinski et al. 2010). 
 
BP: blood platelet, F: factor, fbg: fibrinogen, PM: particulate matter, TF: tissue factor, UFP: ultra-fine 
particles, WBC: white blood cell 
Fig. 2. Biological pathways linking PM exposure and venous thrombosis 
A role for microvesicles has been suggested by the work of Bonzini et al., investigating 
blood samples collected in steel-production plant workers. Besides shortening the PT, 
elevated PM exposure also enhanced thrombin generation, but only when measured in an 
assay without the exogenous addition of a coagulation trigger or negatively charged 
phospholipids  (Bonzini et al. 2010). These findings suggest that PM exposure may induce 
the release of small amounts of endogenous TF and/or negatively charged phospholipids 
that may function as triggers of thrombin generation in the assay system. Circulating 
microvesicles might well be the source of these triggers. This hypothesis is corroborated by 
animal studies demonstrating elevated numbers of procoagulant microvesicles, 24 hours 
after intratracheal instillation of carbon nanotubes in mice (Nemmar et al. 2007). Likewise, 
when stimulated ex vivo, blood platelets from mice exposed to concentrated ambient PM for 
2 weeks released more microvesicles relative to platelets from ambient air-exposed control 
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animals (Wilson et al. 2010). However, observational or controlled exposure studies in 
humans are needed for further confirmation. Figure 2 summarizes the possible 
pathophysiological pathways linking PM exposure and venous thrombogenicity. 
5. Endothelial function and fibrinolysis 
The effects of air pollution on the endothelial function and the fibrinolytic system have 
mainly been investigated in controlled exposure studies by 2 research groups who joined 
forces. The groups of Newby and Blomberg used exposure chambers to expose healthy and 
compromised volunteers to the diluted exhaust of an iddling diesel engine for several hours 
in randomized cross-over studies. They demonstrated an impaired bradykinin-induced 
endothelial release of tissue plasminogen activator (t-PA) upon diesel exhaust inhalation 
(estimated reduction of net t-PA release of 34%) (Mills et al. 2005, Mills et al. 2007), in 
addition to an attenuated agonist-induced increase in blood flow at 6 hours post-inhalation, 
in the absence of inflammatory changes (Mills et al. 2005). At 24 hours post-inhalation, 
endothelium-dependent vasodilatation (induced by acetylcholine and bradykinin) remained 
impaired, while endothelium-independent vasodilatation (using sodium nitroprusside and 
verapamil) and t-PA release were unaffected, in the presence of mild sytemic inflammation 
(Tornqvist et al. 2007). 
These and other (Bonzini et al. 2010, Chuang et al. 2007, Ghio et al. 2003, Samet et al. 2009) 
studies did not demonstrate an assocation between PM exposure and baseline levels (not 
bradykinin-induced) of t-PA. 
While studies, based on controlled exposure to diluted diesel exhaust (Mills et al. 2007, 
Tornqvist et al. 2007, Carlsten et al. 2007) or concentrated ambient particles (Ghio et al. 
2003), did not observe increases in the levels of plasminogen activator inhibitor-1 (PAI-1), 
some epidemiological or animal studies, focussing on urban PM, did: a study in 76 young 
healthy students demonstrated elevated PAI-1 concentrations in association with the mean 
PM2.5 or PM10 concentration at their university's campus over 1 to 3 days (Chuang et al. 
2007). Likewise, urban PM upregulated PAI-1 levels, 24 hours after intratracheal instillation 
in mice (Cozzi et al. 2007). 
PM exposure could also impair the endothelial repair mechanisms by reducing the number 
of endothelial progenitor cells, as demonstrated by a recent report (O'Toole et al. 2010). 
Taken together, these studies indicate a potential deleterious effect of PM inhalation on the 
endothelial and fibrinolytic function that may aggravate the prothrombotic phenotype 
induced by blood platelet and coagulation activation. 
6. Conclusions 
A wide array of epidemiological and experimental studies have provided persuasive 
evidence that air pollutants, the PM fraction in particular, contribute to cardiovascular 
morbidity and mortality. By virtue of the heterogeneity in both study design and the 
composition of the PM considered by these studies, it is not surprising that not all findings 
have been consistent. However, considering the overall weight of scientific evidence, some 
general conclusions can be drawn: through the induction of inflammation and oxidative 
stress, the inhalation of particulates, especially the finest fractions (PM2.5 and UFP), over 
longer time periods contributes to atherosclerotic plaque formation. At shorter time points 
(<24 h), these particles may induce plaque rupture and activate blood platelets, leading to 
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acute peripheral arterial events such as myocardial infarction. Blood platelet activation 
within the first few hours is inflammation-independent, most probably resulting from direct 
contact with systemically translocated particles and/or activated endothelium. Thereafter, 
inflammatory changes are responsible for further platelet activation. 
Although evidence linking PM exposure with venous thromboembolic events is less 
established than with arterial events and warrants further investigation, recent findings 
suggest that chronic air pollution exposure is also a risk factor for venous thrombosis. 
Inflammatory changes, along with the generation of circulating procoagulant microvesicles 
might be of larger importance than coagulation factor upregulation, favoring a role for the 
larger particles (PM10) with higher pro-inflammatory endotoxin content on their surface. 
Air pollution exposure may not be the highest risk factor for arterial or venous thrombosis 
on an individual level. However, because of the huge number of persons exposed, on a 
global scale it is a major, and more importantly, a modifiable risk factor for cardiovascular 
disease and mortality. 
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This book aims to strengthen the knowledge base dealing with Air Pollution. The book consists of 21 chapters
dealing with Air Pollution and its effects in the fields of Health, Environment, Economy and Agricultural
Sources. It is divided into four sections. The first one deals with effect of air pollution on health and human
body organs. The second section includes the Impact of air pollution on plants and agricultural sources and
methods of resistance. The third section includes environmental changes, geographic and climatic conditions
due to air pollution. The fourth section includes case studies concerning of the impact of air pollution in the
economy and development goals, such as, indoor air pollution in México, indoor air pollution and millennium
development goals in Bangladesh, epidemiologic and economic impact of natural gas on indoor air pollution in
Colombia and economic growth and air pollution in Iran during development programs. In this book the
authors explain the definition of air pollution, the most important pollutants and their different sources and
effects on humans and various fields of life. The authors offer different solutions to the problems resulting from
air pollution.
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